Trending...
- Over $261 Billion in Federal Housing Funds Misaligned: New Housing Governance System Launches
- Celebrate Children's Day in Tochigi City!
- Twitter's Buzzing! What's the Deal with PhotoG, the AI Everyone's Talking About?
TORONTO - illiNews -- Meditech International Inc. (BIOFLEX), the makers of world-renowned Red Light and Laser Therapy (RLT) systems, is pleased to continue/extend its official sponsorship as proud Red Light Therapy Provider of the Los Angeles Rams. This ongoing collaboration continues to integrate BIOFLEX's cutting-edge technologies into the Rams' elite training and performance management programs with remarkable results for athlete recovery, pain relief, and performance optimization.
As the industry leader in Red Light and Laser Therapy technologies since 1989, BIOFLEX remains at the forefront of innovation in non-invasive, drug-free treatment options. Also known as photobiomodulation therapy (PBMT) or cold laser therapy, RLT offers a wide range of therapeutic benefits including pain relief, reduced inflammation and stiffness, increased range of motion, decreased risk of reinjury, and accelerated recovery time—making it a vital tool for high-performance athletes.
Newly appointed CEO of Meditech International, Kipton Lade, emphasized the company's commitment to building on this powerful alliance. "We're proud to continue our relationship with the Los Angeles Rams, whose dedication to innovations in player health and performance aligns perfectly with our mission," said Mr. Lade. "BIOFLEX technology has already made a tangible impact in keeping athletes on the playing field and performing at their peak. This partnership reflects our shared vision of long-term, high-performance success."
More on illi News
BIOFLEX's advanced RLT systems are among the most sophisticated in the world, used across over 35 countries and in the treatment of a wide array of medical conditions—many of which have proven resistant to conventional therapies. For over three decades, BIOFLEX has set the gold standard for Red Light Therapy in both clinical and athletic settings.
"As our players return to the field for training, we are thrilled to continue our partnership with BIOFLEX ," said Jennifer Prince, Chief Commercial Officer, Los Angeles Rams. "Our performance team relies on BIOFLEX's innovative systems as part of our best-in-class performance and recovery protocol, and we look forward to strengthening this relationship beyond the training room."
This collaboration underscores BIOFLEX's position as a trusted partner in professional sports and reinforces its role in delivering science-backed, performance-enhancing solutions to some of the world's top athletes.
About BIOFLEX
Established in 1989, BIOFLEX is a global leader in Red Light and Laser Therapy systems. With over 33 years of clinical success, BIOFLEX technologies are used by healthcare professionals and elite sports organizations around the world to treat a wide range of conditions and optimize physical performance.
More on illi News
About Los Angeles Rams
The Los Angeles Rams – Los Angeles' original professional sports team and Super Bowl LVI Champions – stand as one of the oldest franchises in the National Football League and since its founding in 1937, have garnered four World Championships and sent 30 of its members to the Pro Football Hall of Fame. As a professional sports team, the organization is committed to be a valuable civic partner and serving the greater Los Angeles area 365 days a year. The Rams play their home games at SoFi Stadium, which is located at Hollywood Park, a 298-acre sports and entertainment destination owned, being developed and operated by Los Angeles Rams Owner/Chairman E. Stanley Kroenke in Inglewood, CA.
For media inquiries, please contact:
Kipton Lade, CEO, Meditech International Inc.
kipton@bioflexlaser.com
www.bioflexlaser.com
Priya Bhambri
Corporate Communications, Los Angeles Rams
pbhambri@rams.nfl.com
www.therams.com
As the industry leader in Red Light and Laser Therapy technologies since 1989, BIOFLEX remains at the forefront of innovation in non-invasive, drug-free treatment options. Also known as photobiomodulation therapy (PBMT) or cold laser therapy, RLT offers a wide range of therapeutic benefits including pain relief, reduced inflammation and stiffness, increased range of motion, decreased risk of reinjury, and accelerated recovery time—making it a vital tool for high-performance athletes.
Newly appointed CEO of Meditech International, Kipton Lade, emphasized the company's commitment to building on this powerful alliance. "We're proud to continue our relationship with the Los Angeles Rams, whose dedication to innovations in player health and performance aligns perfectly with our mission," said Mr. Lade. "BIOFLEX technology has already made a tangible impact in keeping athletes on the playing field and performing at their peak. This partnership reflects our shared vision of long-term, high-performance success."
More on illi News
- Naperville: Inauguration of City Council Members Taking Place Sunday, May 4
- Divorce-Online Marks 25 Years Transforming Family Law Services in the UK
- Tampa-Based Digital Marketing Agency Launches New Website to Help Local Businesses Grow Online
- GRAINGER NAMES MELANIE TINTO AS CHIEF HUMAN RESOURCES OFFICER
- myb.day Launches New Birthday Gift Shop Filled With Personalized Surprises
BIOFLEX's advanced RLT systems are among the most sophisticated in the world, used across over 35 countries and in the treatment of a wide array of medical conditions—many of which have proven resistant to conventional therapies. For over three decades, BIOFLEX has set the gold standard for Red Light Therapy in both clinical and athletic settings.
"As our players return to the field for training, we are thrilled to continue our partnership with BIOFLEX ," said Jennifer Prince, Chief Commercial Officer, Los Angeles Rams. "Our performance team relies on BIOFLEX's innovative systems as part of our best-in-class performance and recovery protocol, and we look forward to strengthening this relationship beyond the training room."
This collaboration underscores BIOFLEX's position as a trusted partner in professional sports and reinforces its role in delivering science-backed, performance-enhancing solutions to some of the world's top athletes.
About BIOFLEX
Established in 1989, BIOFLEX is a global leader in Red Light and Laser Therapy systems. With over 33 years of clinical success, BIOFLEX technologies are used by healthcare professionals and elite sports organizations around the world to treat a wide range of conditions and optimize physical performance.
More on illi News
- DuoKey to Unveil Encrypted Financial Intelligence Use Case at GISEC Global 2025
- Cboe Global Markets Appoints Craig Donohue as New CEO USA - English APAC - English
- Mission 3A Establishes Healthcare Advisory Board with Addition of Industry Leaders Patrick Fisher, Kevin Cordell, and Dr. Greg Berlet
- SSATI Completes Acquisition of Invex Technology Solutions and ITIC Corporation's Government Support Services
- Indies United is pleased to present our May 2025 book releases
About Los Angeles Rams
The Los Angeles Rams – Los Angeles' original professional sports team and Super Bowl LVI Champions – stand as one of the oldest franchises in the National Football League and since its founding in 1937, have garnered four World Championships and sent 30 of its members to the Pro Football Hall of Fame. As a professional sports team, the organization is committed to be a valuable civic partner and serving the greater Los Angeles area 365 days a year. The Rams play their home games at SoFi Stadium, which is located at Hollywood Park, a 298-acre sports and entertainment destination owned, being developed and operated by Los Angeles Rams Owner/Chairman E. Stanley Kroenke in Inglewood, CA.
For media inquiries, please contact:
Kipton Lade, CEO, Meditech International Inc.
kipton@bioflexlaser.com
www.bioflexlaser.com
Priya Bhambri
Corporate Communications, Los Angeles Rams
pbhambri@rams.nfl.com
www.therams.com
Source: Meditech International Inc.
0 Comments
Latest on illi News
- Swim Stroke Doctor, Secures Patent for Groundbreaking Swim Cap That Improves Performance Through
- Anern Launches New Generation of Lithium Solar Batteries, Empowering a Smarter, Greener Future
- K2 Integrity and the Institute for Financial Integrity Launch AML/CFT Course for Investment Advisers
- Buttcoin - The Next Bitcoin Foundation Explores First Spot Buttcoin ($BUTTCOIN) ETP Listing on Switzerland's SIX Exchange
- Start Dogecoin cloud mining with XY Miners and maximize your passive income
- J INTS BIO Presents Research Results for Next-Generation Innovative Anticancer Therapeutics 'JIN-A02' and 'JIN-001' at AACR 2025
- New Report Highlights the Most Dangerous States for Transportation and Warehouse Workers
- City Of Chicago Joins Nationwide Coalition in Lawsuit to Challenge the Trump Administration's Unlawful Firing of Federal Employees
- Seecoin Expands Beyond Gaming: A Web3 (r)evolution for All Content Creators
- Barcelona-based Neurosurgical Specialist Awarded Designation of International Center of Excellence for Ehlers Danlos Syndrome
- Pregis Expands Multi-Layer Technology for High-Performance Barrier Films at Anderson Facility
- InventHelp Inventor Develops New Makeup Application Machine (CHK-1097)
- New Professional Association to Study Principles of Hospitality Applied to the Delivery of Healthcare
- Clinical Endpoints Successfully Met in Study for Groundbreaking 12-Lead ECG Synthesis Technology Allowing Software Application to FDA: HeartBeam, Inc
- DATA BREACH ALERT: Edelson Lechtzin LLP Is Investigating Claims On Behalf Of Medical Express Ambulance, Inc. Customers Whose Data May Have Been Compromised
- Boston Industrial Solutions, Inc. Unveils Natron® 504N UV LED Inks Designed for EPSON Printheads
- Kavelle Christie: Trump's First 100 Days Mark Alarming Breakdown in Healthcare, Public Health, and Freedoms
- Naperville: 100 Block Locust Court Structure Fire
- Naperville: Bulk Brush Collection to Help Residents With Spring Yard Clean-Ups
- Late-Breaking Research from SK Life Science Labs at AACR Annual Meeting Shows p300-Selective Degraders are Potent Growth Inhibitors in Models of Aggressive Prostate Cancers and Solid Tumors